57736-32-0 Usage
Uses
Used in Chemical Synthesis:
4-n-Undecyloxyaniline is used as a key intermediate in the synthesis of various organic compounds, contributing to the development of a wide range of chemical products.
Used in Dye and Pigment Production:
As an intermediate, 4-n-Undecyloxyaniline is used in the production of dyes and pigments, playing a crucial role in the creation of colorants for different industries.
Used in Pharmaceutical Manufacturing:
4-n-Undecyloxyaniline is utilized in the manufacturing of pharmaceuticals, potentially contributing to the development of new drugs and medicinal compounds.
Used in Rubber Chemicals Production:
4-n-Undecyloxyaniline is also employed in the production of rubber chemicals, which are essential for enhancing the properties and performance of rubber products.
Used in Organic Electronics and Optoelectronics:
Due to its unique structure and properties, 4-n-Undecyloxyaniline has potential applications in the field of organic electronics and optoelectronic devices, where it may be used to improve the performance of these advanced technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 57736-32-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,7,3 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 57736-32:
(7*5)+(6*7)+(5*7)+(4*3)+(3*6)+(2*3)+(1*2)=150
150 % 10 = 0
So 57736-32-0 is a valid CAS Registry Number.
InChI:InChI=1/C17H29NO/c1-2-3-4-5-6-7-8-9-10-15-19-17-13-11-16(18)12-14-17/h11-14H,2-10,15,18H2,1H3
57736-32-0Relevant academic research and scientific papers
Design and synthesis of boronic acid inhibitors of endothelial lipase
O'Connell, Daniel P.,Leblanc, Daniel F.,Cromley, Debra,Billheimer, Jeffrey,Rader, Daniel J.,Bachovchin, William W.
, p. 1397 - 1401 (2012/03/26)
Endothelial lipase (EL) and lipoprotein lipase (LPL) are homologous lipases that act on plasma lipoproteins. EL is predominantly a phospholipase and appears to be a key regulator of plasma HDL-C. LPL is mainly a triglyceride lipase regulating (V)LDL levels. The existing biological data indicate that inhibitors selective for EL over LPL should have anti-atherogenic activity, mainly through increasing plasma HDL-C levels. We report here the synthesis of alkyl, aryl, or acyl-substituted phenylboronic acids that inhibit EL. Many of the inhibitors evaluated proved to be nearly equally potent against both EL and LPL, but several exhibited moderate to good selectivity for EL.
Liquid-crystalline polymorphism of symmetrical azobananas: Bis(4-(4-alkylphenyl)azophenyl) 2-nitroisophtalates
Zygadlo,Dardas,Nowicka,Hofmann,Galewski
, p. 283 - 291 (2011/08/02)
In this paper we present a series of novel compounds, bis(4-(4-alkylphenyl) azophenyl) 2-nitroisophtalates, which exhibit nematic and banana-type liquidcrystalline phases. The alkyl chain length varies from 1 to 18 carbons. The first ten members of this series exhibit nematic phase. The last eleven compounds exhibit banana-type liquid crystalline phases. The propyl and pentyl derivatives have extra second type of banana mesophase. Copyright Taylor & Francis Group, LLC.
